453 related articles for article (PubMed ID: 18931679)
1. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9.
Park B; Brinkmann MM; Spooner E; Lee CC; Kim YM; Ploegh HL
Nat Immunol; 2008 Dec; 9(12):1407-14. PubMed ID: 18931679
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 processing: the key event in Toll-like receptor 9 activation?
Bauer S
Immunol Lett; 2013 Jan; 149(1-2):85-7. PubMed ID: 23183093
[TBL] [Abstract][Full Text] [Related]
3. Cathepsins are required for Toll-like receptor 9 responses.
Matsumoto F; Saitoh S; Fukui R; Kobayashi T; Tanimura N; Konno K; Kusumoto Y; Akashi-Takamura S; Miyake K
Biochem Biophys Res Commun; 2008 Mar; 367(3):693-9. PubMed ID: 18166152
[TBL] [Abstract][Full Text] [Related]
4. Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Events.
Sinha SS; Cameron J; Brooks JC; Leifer CA
J Immunol; 2016 Aug; 197(4):1343-52. PubMed ID: 27421483
[TBL] [Abstract][Full Text] [Related]
5. TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking.
Kasperkovitz PV; Cardenas ML; Vyas JM
J Immunol; 2010 Dec; 185(12):7614-22. PubMed ID: 21059889
[TBL] [Abstract][Full Text] [Related]
6. Negative self-regulation of TLR9 signaling by its N-terminal proteolytic cleavage product.
Lee S; Kang D; Ra EA; Lee TA; Ploegh HL; Park B
J Immunol; 2014 Oct; 193(7):3726-35. PubMed ID: 25187653
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice.
Avalos AM; Kirak O; Oelkers JM; Pils MC; Kim YM; Ottinger M; Jaenisch R; Ploegh HL; Brinkmann MM
J Immunol; 2013 Jan; 190(2):695-702. PubMed ID: 23241879
[TBL] [Abstract][Full Text] [Related]
8. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages.
De Nardo D; De Nardo CM; Nguyen T; Hamilton JA; Scholz GM
J Immunol; 2009 Dec; 183(12):8110-8. PubMed ID: 19923461
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses.
Kimura T; Endo S; Inui M; Saitoh S; Miyake K; Takai T
J Immunol; 2015 Jun; 194(11):5426-36. PubMed ID: 25917084
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B-Deficient Mice Resolve Leishmania major Inflammation Faster in a T Cell-Dependent Manner.
Rasid O; Mériaux V; Khan EM; Borde C; Ciulean IS; Fitting C; Manoury B; Cavaillon JM; Doyen N
PLoS Negl Trop Dis; 2016 May; 10(5):e0004716. PubMed ID: 27182703
[TBL] [Abstract][Full Text] [Related]
11. Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages.
Tsai CY; Lu SL; Hu CW; Yeh CS; Lee GB; Lei HY
J Immunol; 2012 Jan; 188(1):68-76. PubMed ID: 22156340
[TBL] [Abstract][Full Text] [Related]
12. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
[TBL] [Abstract][Full Text] [Related]
13. Pivotal role of ADP-ribosylation factor 6 in Toll-like receptor 9-mediated immune signaling.
Wu JY; Kuo CC
J Biol Chem; 2012 Feb; 287(6):4323-34. PubMed ID: 22170068
[TBL] [Abstract][Full Text] [Related]
14. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor.
Ewald SE; Lee BL; Lau L; Wickliffe KE; Shi GP; Chapman HA; Barton GM
Nature; 2008 Dec; 456(7222):658-62. PubMed ID: 18820679
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate oxidation acidifies endosomes, regulating antigen processing and TLR9 signaling.
Lewis CJ; Cobb BA
J Immunol; 2010 Apr; 184(7):3789-800. PubMed ID: 20200279
[TBL] [Abstract][Full Text] [Related]
16. Toll-Like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar Typhimurium infection.
Zhan R; Han Q; Zhang C; Tian Z; Zhang J
Infect Immun; 2015 Apr; 83(4):1641-9. PubMed ID: 25667264
[TBL] [Abstract][Full Text] [Related]
17. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.
Ivanov S; Dragoi AM; Wang X; Dallacosta C; Louten J; Musco G; Sitia G; Yap GS; Wan Y; Biron CA; Bianchi ME; Wang H; Chu WM
Blood; 2007 Sep; 110(6):1970-81. PubMed ID: 17548579
[TBL] [Abstract][Full Text] [Related]
18. Granulin is a soluble cofactor for toll-like receptor 9 signaling.
Park B; Buti L; Lee S; Matsuwaki T; Spooner E; Brinkmann MM; Nishihara M; Ploegh HL
Immunity; 2011 Apr; 34(4):505-13. PubMed ID: 21497117
[TBL] [Abstract][Full Text] [Related]
19. Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9.
Avalos AM; Ploegh HL
Eur J Immunol; 2011 Oct; 41(10):2820-7. PubMed ID: 21766476
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
